Copyright Reports & Markets. All rights reserved.

Global Erythromycin Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 Erythromycin Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Erythromycin Thiocyanate
      • 1.2.2 Azithromycin
      • 1.2.3 Clarithromycin
      • 1.2.4 Roxithromycin
      • 1.2.5 Others
    • 1.3 Market Analysis by Applications
      • 1.3.1 Human Medication
      • 1.3.2 Veterinary Medication
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Kelun Chuanning Biotechnology
      • 2.1.1 Business Overview
      • 2.1.2 Erythromycin Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Kelun Chuanning Biotechnology Erythromycin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Ercros S.A.
      • 2.2.1 Business Overview
      • 2.2.2 Erythromycin Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Ercros S.A. Erythromycin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 HEC Group
      • 2.3.1 Business Overview
      • 2.3.2 Erythromycin Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 HEC Group Erythromycin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Envee Drugs Pvt Ltd
      • 2.4.1 Business Overview
      • 2.4.2 Erythromycin Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Envee Drugs Pvt Ltd Erythromycin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Mehta Api
      • 2.5.1 Business Overview
      • 2.5.2 Erythromycin Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Mehta Api Erythromycin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Abbvie
      • 2.6.1 Business Overview
      • 2.6.2 Erythromycin Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Abbvie Erythromycin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Ningxia Qiyuan
      • 2.7.1 Business Overview
      • 2.7.2 Erythromycin Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Ningxia Qiyuan Erythromycin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Calyx C & P
      • 2.8.1 Business Overview
      • 2.8.2 Erythromycin Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Calyx C & P Erythromycin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Alembic Pharma
      • 2.9.1 Business Overview
      • 2.9.2 Erythromycin Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Alembic Pharma Erythromycin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 SM Biomed
      • 2.10.1 Business Overview
      • 2.10.2 Erythromycin Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 SM Biomed Erythromycin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Anuh Pharma
      • 2.11.1 Business Overview
      • 2.11.2 Erythromycin Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Anuh Pharma Erythromycin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Shaoxing Hantai Pharma
      • 2.12.1 Business Overview
      • 2.12.2 Erythromycin Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Shaoxing Hantai Pharma Erythromycin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Erythromycin Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Erythromycin Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Erythromycin Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Erythromycin Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Erythromycin Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Erythromycin Market Analysis by Regions

    • 4.1 Global Erythromycin Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Erythromycin Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Erythromycin Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Erythromycin Sales and Growth Rate (2014-2019)
    • 4.3 Europe Erythromycin Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Erythromycin Sales and Growth Rate (2014-2019)
    • 4.5 South America Erythromycin Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Erythromycin Sales and Growth Rate (2014-2019)

    5 North America Erythromycin by Country

    • 5.1 North America Erythromycin Sales, Revenue and Market Share by Country
      • 5.1.1 North America Erythromycin Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Erythromycin Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Erythromycin Sales and Growth Rate (2014-2019)
    • 5.3 Canada Erythromycin Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Erythromycin Sales and Growth Rate (2014-2019)

    6 Europe Erythromycin by Country

    • 6.1 Europe Erythromycin Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Erythromycin Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Erythromycin Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Erythromycin Sales and Growth Rate (2014-2019)
    • 6.3 UK Erythromycin Sales and Growth Rate (2014-2019)
    • 6.4 France Erythromycin Sales and Growth Rate (2014-2019)
    • 6.5 Russia Erythromycin Sales and Growth Rate (2014-2019)
    • 6.6 Italy Erythromycin Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Erythromycin by Country

    • 7.1 Asia-Pacific Erythromycin Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Erythromycin Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Erythromycin Revenue and Market Share by Country (2014-2019)
    • 7.2 China Erythromycin Sales and Growth Rate (2014-2019)
    • 7.3 Japan Erythromycin Sales and Growth Rate (2014-2019)
    • 7.4 Korea Erythromycin Sales and Growth Rate (2014-2019)
    • 7.5 India Erythromycin Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Erythromycin Sales and Growth Rate (2014-2019)

    8 South America Erythromycin by Country

    • 8.1 South America Erythromycin Sales, Revenue and Market Share by Country
      • 8.1.1 South America Erythromycin Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Erythromycin Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Erythromycin Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Erythromycin Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Erythromycin Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Erythromycin by Countries

    • 9.1 Middle East and Africa Erythromycin Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Erythromycin Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Erythromycin Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Erythromycin Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Erythromycin Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Erythromycin Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Erythromycin Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Erythromycin Sales and Growth Rate (2014-2019)

    10 Global Erythromycin Market Segment by Type

    • 10.1 Global Erythromycin Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Erythromycin Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Erythromycin Revenue and Market Share by Type (2014-2019)
    • 10.2 Erythromycin Thiocyanate Sales Growth and Price
      • 10.2.1 Global Erythromycin Thiocyanate Sales Growth (2014-2019)
      • 10.2.2 Global Erythromycin Thiocyanate Price (2014-2019)
    • 10.3 Azithromycin Sales Growth and Price
      • 10.3.1 Global Azithromycin Sales Growth (2014-2019)
      • 10.3.2 Global Azithromycin Price (2014-2019)
    • 10.4 Clarithromycin Sales Growth and Price
      • 10.4.1 Global Clarithromycin Sales Growth (2014-2019)
      • 10.4.2 Global Clarithromycin Price (2014-2019)
    • 10.5 Roxithromycin Sales Growth and Price
      • 10.5.1 Global Roxithromycin Sales Growth (2014-2019)
      • 10.5.2 Global Roxithromycin Price (2014-2019)
    • 10.6 Others Sales Growth and Price
      • 10.6.1 Global Others Sales Growth (2014-2019)
      • 10.6.2 Global Others Price (2014-2019)

    11 Global Erythromycin Market Segment by Application

    • 11.1 Global Erythromycin Sales Market Share by Application (2014-2019)
    • 11.2 Human Medication Sales Growth (2014-2019)
    • 11.3 Veterinary Medication Sales Growth (2014-2019)

    12 Erythromycin Market Forecast (2019-2024)

    • 12.1 Global Erythromycin Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Erythromycin Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Erythromycin Market Forecast (2019-2024)
      • 12.2.2 Europe Erythromycin Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Erythromycin Market Forecast (2019-2024)
      • 12.2.4 South America Erythromycin Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Erythromycin Market Forecast (2019-2024)
    • 12.3 Erythromycin Market Forecast by Type (2019-2024)
      • 12.3.1 Global Erythromycin Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Erythromycin Market Share Forecast by Type (2019-2024)
    • 12.4 Erythromycin Market Forecast by Application (2019-2024)
      • 12.4.1 Global Erythromycin Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Erythromycin Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Erythromycin is an antibiotic useful for the treatment of a number of bacterial infections. This includes respiratory tract infections, skin infections, chlamydia infections, pelvic inflammatory disease, and syphilis. It may also be used during pregnancy to prevent Group B streptococcal infection in the newborn, as well as to improve delayed stomach emptying. It can be given intravenously and by mouth. An eye ointment is routinely recommended after delivery to prevent eye infections in the newborn.

      Scope of the Report:
      The worldwide market for Erythromycin is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
      This report focuses on the Erythromycin in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Market Segment by Manufacturers, this report covers
      Kelun Chuanning Biotechnology
      Ercros S.A.
      HEC Group
      Envee Drugs Pvt Ltd
      Mehta Api
      Abbvie
      Ningxia Qiyuan
      Calyx C & P
      Alembic Pharma
      SM Biomed
      Anuh Pharma
      Shaoxing Hantai Pharma

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia etc.)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Erythromycin Thiocyanate
      Azithromycin
      Clarithromycin
      Roxithromycin
      Others

      Market Segment by Applications, can be divided into
      Human Medication
      Veterinary Medication

      The content of the study subjects, includes a total of 15 chapters:
      Chapter 1, to describe Erythromycin product scope, market overview, market opportunities, market driving force and market risks.
      Chapter 2, to profile the top manufacturers of Erythromycin, with price, sales, revenue and global market share of Erythromycin in 2017 and 2018.
      Chapter 3, the Erythromycin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
      Chapter 4, the Erythromycin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
      Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
      Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
      Chapter 12, Erythromycin market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
      Chapter 13, 14 and 15, to describe Erythromycin sales channel, distributors, customers, research findings and conclusion, appendix and data source.

      Buy now